Researchers are using the Argonne Leadership Computing Facility to design and model peptide therapeutics. Which of the following is NOT a challenge associated with peptide therapeutics?
W) They are difficult to deliver
X) They have poor specificity
Y) They have poor cell penetration
Z) They are degraded in the circulatory system
✔️Answer:X) THEY HAVE POOR SPECIFICITY
🚀
Take Your Prep to the Next Level
Practice with interactive modes, adaptive testing, and detailed stats on our main app.